European equities traded in the US as American depositary receipts were trending lower late Friday morning, declining 0.28% to 1,891.30 on the S&P Europe Select ADR Index, which is off 0.20% for the week so far.
From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and petroleum refiner Equinor (EQNR), which climbed 5.8% and 4.7% respectively. They were followed by oil and gas company Eni (E) and telecommunications company Nokia (NOK), which advanced 3.9% and 3.8% respectively.
The decliners from continental Europe were led by lenders ING (ING) and Banco Bilbao Vizcaya Argentaria (BBVA), which fell 2.6% and 2% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and lender Banco Santander (SAN), which were down 1.9% and 1.5% respectively.
The gainers from the UK were led by biopharmaceutical company NuCana (NCNA) and oil and gas company BP (BP), which rose 4.2% and 2.3% respectively. They were followed by oil and gas company Shell (SHEL) and medical device maker Smith & Nephew (SNN), which increased 1.9% and 0.2% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and software firm Endava (DAVA), which dropped 5.9% and 4.2% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and hospitality company InterContinental Hotels Group (IHG), which lost 4.1% and 3.4% respectively.
Source: finance.yahoo.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.
